Get started
Author

Mennatallah Abdallah

Observed name: Mennatallah M. Abdallah
ORCID: 0009-0008-3797-8033
Observed ORCID: 0009-0008-3797-8033
OpenAlex ID: A5016515509
Synthesis and evaluation of novel N1-acylated 5-(4-pyridinyl)indazole derivatives as potent and selective haspin inhibitors
2024 · Mona M. Shawky, Mennatallah Abdallah, et al. · Bioorganic Chemistry · 6
N1‐Benzoylated 5‐(4‐pyridinyl)indazole‐based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents
2024 · Habiba G. Aboelfotouh, Mennatallah Abdallah, et al. · Archiv der Pharmazie · 5
PDF
Enhanced antibacterial action against Pseudomonas aeruginosa via the electromechanical synergy of nanocurcumin mesoporous silica and piezoelectric PVDF nanofibers
2026 · Mai.I. El-kaliuoby, Mennatallah M. Abdallah, et al. · The European Physical Journal Plus · 2
Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier
2021 · Mennatallah Abdallah, Mostafa M. Hamed, et al. · European Journal of Medicinal Chemistry · 2
Recent Advances in the Synthesis of Spiroindolines: Catalytic Strategies, Stereoselectivity, and Synthetic Utility (2020–2025)
2026 · Parthiena M. Keddis, Ahmed Mamdouh Antar, et al. · Molecules
Lead-guided prodrug development of small molecules as GLP-1R agonists
2026 · Hannah Lentschat, Habiba G. Aboelfotouh, et al. · Bioorganic Chemistry
An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)
2026 · Mennatallah Abdallah, Parthiena M. Keddis, et al. · Expert Opinion on Therapeutic Patents
An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)
2026 · Mennatallah Abdallah, Parthiena M. Keddis, et al. · Figshare
Works count: 8
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type